Pilot studies to develop small molecule inhibitors and degraders targeting Henipavirus | Pandemic PACT Tracker

Key facts

Disease
Infection caused by Nipah virus
start year
2022
Known Financial Commitments (USD)
$2,695.47
Funder
Novo Nordisk Foundation
Principal Investigator
N/A
Research Location
United States of America
Lead Research Institution
Stanford University
Research Priority Alignment
N/A

Research Category
Therapeutics research, development and implementation
Research Subcategory
Pre-clinical studies
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable

Abstract

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Role of voltage-gated Ca²⁺ channel dysfunction in gastric vagal afferent neuropathy following spinal cord injury.

Outcomes in pregnant patients with congenital heart disease by rurality.

Autophagy activator AA-20 improves proteostasis and extends <i>Caenorhabditis elegans</i> lifespan.

Islet environment and development of type 1 diabetes in the biobreeding rat model.

β-Cell Function Derived From Routine Clinical Measures Reports and Predicts Treatment Response to Immunotherapy in Recent-Onset Type 1 Diabetes.

Targeting Tmem63b and Piezo2 in C-fiber low threshold mechanoreceptor: limitation of Vglut3-IRES-Cre

The association between adverse childhood experiences and mental disorders among adolescents in Kenya, Indonesia, and Vietnam: Evidence from the National Adolescent Mental Health Surveys.

Brain biomechanics governs mitotic fidelity of embryonic neural progenitors

T-cell Dependency of Tumor Regressions and Complete Responses with RAS(ON) Multi-selective Inhibition in Preclinical Models of Pancreatic Ductal Adenocarcinoma.